Fumito Wada

422 total citations
21 papers, 323 citations indexed

About

Fumito Wada is a scholar working on Molecular Biology, Biochemistry and Cancer Research. According to data from OpenAlex, Fumito Wada has authored 21 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 2 papers in Biochemistry and 2 papers in Cancer Research. Recurrent topics in Fumito Wada's work include Advanced biosensing and bioanalysis techniques (17 papers), DNA and Nucleic Acid Chemistry (14 papers) and RNA Interference and Gene Delivery (12 papers). Fumito Wada is often cited by papers focused on Advanced biosensing and bioanalysis techniques (17 papers), DNA and Nucleic Acid Chemistry (14 papers) and RNA Interference and Gene Delivery (12 papers). Fumito Wada collaborates with scholars based in Japan, Czechia and United States. Fumito Wada's co-authors include Tsuyoshi Yamamoto, Satoshi Obika, Mariko Harada‐Shiba, Hidenori Yasuhara, Shinichiro Hori, Asako Yamayoshi, Kenji Nakano, Fuminori Hyodo, Sumalee Obchoei and Takeshi Imanishi and has published in prestigious journals such as Nucleic Acids Research, Journal of Controlled Release and The Journal of Organic Chemistry.

In The Last Decade

Fumito Wada

21 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumito Wada Japan 12 293 31 19 16 15 21 323
Mira I. Pronobis United States 9 280 1.0× 18 0.6× 30 1.6× 26 1.6× 7 0.5× 13 320
Dmitri Segal Canada 6 242 0.8× 37 1.2× 23 1.2× 33 2.1× 12 0.8× 7 291
Siddharth Shukla United States 7 416 1.4× 91 2.9× 8 0.4× 21 1.3× 9 0.6× 10 449
Hidenori Yasuhara Japan 8 206 0.7× 22 0.7× 11 0.6× 6 0.4× 4 0.3× 10 245
Jennifer Bolsée Belgium 8 212 0.7× 39 1.3× 59 3.1× 39 2.4× 8 0.5× 13 303
Hui Si Kwok United States 10 200 0.7× 38 1.2× 39 2.1× 36 2.3× 5 0.3× 12 258
Alessandra Di Lorenzo United States 7 630 2.2× 22 0.7× 31 1.6× 29 1.8× 8 0.5× 7 674
Pelin Sahlén Sweden 10 263 0.9× 47 1.5× 17 0.9× 71 4.4× 6 0.4× 20 340
Emil M.H. Pallesen Denmark 7 185 0.6× 48 1.5× 12 0.6× 28 1.8× 27 1.8× 9 267
Zu Ye China 11 225 0.8× 33 1.1× 72 3.8× 21 1.3× 7 0.5× 26 307

Countries citing papers authored by Fumito Wada

Since Specialization
Citations

This map shows the geographic impact of Fumito Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumito Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumito Wada more than expected).

Fields of papers citing papers by Fumito Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumito Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumito Wada. The network helps show where Fumito Wada may publish in the future.

Co-authorship network of co-authors of Fumito Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Fumito Wada. A scholar is included among the top collaborators of Fumito Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumito Wada. Fumito Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wada, Shun‐ichi, et al.. (2023). Prodrug‐Type Phosphotriester Oligonucleotides with Linear Disulfide Promoieties Responsive to Reducing Environment. ChemBioChem. 24(24). e202300526–e202300526. 4 indexed citations
2.
Wada, Fumito, et al.. (2021). Programmed Instability of Ligand Conjugation Manifold for Efficient Hepatocyte Delivery of Therapeutic Oligonucleotides. Nucleic Acid Therapeutics. 31(6). 404–416. 3 indexed citations
3.
Wada, Fumito, Tsuyoshi Yamamoto, Tadayuki Kobayashi, et al.. (2021). Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides. Molecular Therapy — Nucleic Acids. 26. 957–969. 9 indexed citations
4.
Yamamoto, Tsuyoshi, et al.. (2021). Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides. Pharmaceutics. 13(6). 817–817. 16 indexed citations
5.
Wada, Fumito, Shinichiro Hori, Satoshi Obika, & Tsuyoshi Yamamoto. (2020). Calcium-Mediated In Vitro Transfection Technique of Oligonucleotides with Broad Chemical Modification Compatibility. Methods in molecular biology. 2176. 141–154. 2 indexed citations
6.
Wada, Shun‐ichi, Fumito Wada, Osamu Nakagawa, et al.. (2018). Effective gene silencing activity of prodrug-type 2′-O-methyldithiomethyl siRNA compared with non-prodrug-type 2′-O-methyl siRNA. Bioorganic & Medicinal Chemistry Letters. 28(12). 2171–2174. 7 indexed citations
7.
Wada, Fumito, et al.. (2018). Cholesterol–GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides. Nucleic Acid Therapeutics. 28(1). 50–57. 17 indexed citations
8.
9.
Setoguchi, Kiyoko, Lin Cui, Sumalee Obchoei, et al.. (2017). Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes. Molecular Therapy — Nucleic Acids. 9. 170–181. 31 indexed citations
10.
Yamamoto, Tsuyoshi, Fumito Wada, & Mariko Harada‐Shiba. (2016). Development of Antisense Drugs for Dyslipidemia. Journal of Atherosclerosis and Thrombosis. 23(9). 1011–1025. 13 indexed citations
11.
12.
Yamamoto, Tsuyoshi, Akira Kugimiya, Fumito Wada, et al.. (2016). Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, Duplex Stability, Nuclease Resistance, and in Vitro and in Vivo Antisense Potency. The Journal of Organic Chemistry. 82(1). 12–24. 11 indexed citations
13.
Aoyama, Hiroshi, Akira Kugimiya, Tsuyoshi Yamamoto, et al.. (2016). Effect of an N-substituent in sulfonamide-bridged nucleic acid (SuNA) on hybridization ability and duplex structure. Organic & Biomolecular Chemistry. 14(27). 6531–6538. 3 indexed citations
14.
Yamamoto, Tsuyoshi, et al.. (2015). Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides. Bioorganic & Medicinal Chemistry. 24(1). 26–32. 34 indexed citations
15.
Hori, Shinichiro, et al.. (2015). Ca2+enrichment in culture medium potentiates effect of oligonucleotides. Nucleic Acids Research. 43(19). e128–e128. 34 indexed citations
16.
Yamamoto, Tsuyoshi, et al.. (2015). Amido-bridged nucleic acids with small hydrophobic residues enhance hepatic tropism of antisense oligonucleotides in vivo. Organic & Biomolecular Chemistry. 13(12). 3757–3765. 42 indexed citations
17.
Yamamoto, Tsuyoshi, Naoko Fujii, Hidenori Yasuhara, et al.. (2014). Evaluation of Multiple-Turnover Capability of Locked Nucleic Acid Antisense Oligonucleotides in Cell-Free RNase H-Mediated Antisense Reaction and in Mice. Nucleic Acid Therapeutics. 24(4). 283–290. 17 indexed citations
18.
Yamamoto, Tsuyoshi, Satoshi Obika, Hidenori Yasuhara, et al.. (2013). Locked nucleic acid antisense inhibitor targeting apolipoprotein C-III efficiently and preferentially removes triglyceride from large very low-density lipoprotein particles in murine plasma. European Journal of Pharmacology. 723. 353–359. 10 indexed citations
19.
Yamamoto, Tsuyoshi, Hidenori Yasuhara, Fumito Wada, et al.. (2012). Superior Silencing by 2′,4′-BNANC-Based Short Antisense Oligonucleotides Compared to 2′,4′-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors. Journal of Nucleic Acids. 2012. 1–7. 15 indexed citations
20.
Shimada, M., et al.. (1970). Distribution of radioactive sulfur from 35S-L-methionine in adult mice brains in vivo and its chemical analyses.. PubMed. 45(5). 234–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mira I. Pronobis Breakdown of academic impact, for papers by Dmitri Segal Breakdown of academic impact, for papers by Siddharth Shukla Breakdown of academic impact, for papers by Hidenori Yasuhara Breakdown of academic impact, for papers by Jennifer Bolsée Breakdown of academic impact, for papers by Hui Si Kwok Breakdown of academic impact, for papers by Alessandra Di Lorenzo Breakdown of academic impact, for papers by Pelin Sahlén Breakdown of academic impact, for papers by Emil M.H. Pallesen Breakdown of academic impact, for papers by Zu Ye
Rankless by CCL
2026